Bernays S, Paparini S, Gibb D, Seeley J
Department of Social and Environmental Health Research, London School of Hygiene and Tropical Medicine , London , UK.
MRC Clinical Trials Unit at University of College London , London , UK.
Vulnerable Child Youth Stud. 2016 Jan 2;11(1):60-68. doi: 10.1080/17450128.2015.1128581. Epub 2015 Dec 30.
Despite mounting evidence recommending disclosure of human immunodeficiency virus (HIV) status to young people with perinatally acquired HIV as a central motivating factor for adherence to antiretroviral therapy, many young people continue to experience disclosure as a partial event, rather than a process. Drawing from two longitudinal, interview-based qualitative studies with young people living with HIV (aged 10-24) in five different countries in low and high income settings, we present data regarding disclosure and information about HIV in the clinic. The article highlights the limits of discussions framing disclosure and patient literacy, and young people's reluctance to voice their adherence difficulties in the context of their relationships with clinical care teams. We suggest that a clinician-initiated, explicit acknowledgment of the social and practical hurdles of daily adherence for young people would aid a more transparent conversation and encourage young people to disclose missed doses and other problems they may be facing with their treatment. This may help to reduce health harms and poor adherence in the longer-term.
尽管越来越多的证据表明,向围产期感染艾滋病毒的年轻人披露其人类免疫缺陷病毒(HIV)感染状况是坚持抗逆转录病毒治疗的核心驱动因素,但许多年轻人仍将披露视为一个部分事件,而非一个过程。通过对来自低收入和高收入环境中五个不同国家的10至24岁感染艾滋病毒的年轻人进行的两项基于访谈的纵向定性研究,我们呈现了有关诊所中披露情况和艾滋病毒信息的数据。本文强调了围绕披露和患者素养展开讨论的局限性,以及年轻人在与临床护理团队的关系中不愿说出其坚持治疗困难的情况。我们建议,由临床医生主动明确承认年轻人日常坚持治疗所面临的社会和实际障碍,将有助于进行更透明的对话,并鼓励年轻人披露漏服剂量及他们在治疗中可能面临的其他问题。从长远来看,这可能有助于减少健康危害和治疗依从性差的情况。